- Home
- ANGH vs CNTB Comparison
ANGH vs CNTB Comparison
Compare ANGH & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGH
- CNTB
- Stock Information
- Founded
- ANGH 2012
- CNTB 2012
- Country
- ANGH United Arab Emirates
- CNTB United States
- Employees
- ANGH N/A
- CNTB N/A
- Industry
- ANGH Telecommunications Equipment
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- ANGH Consumer Discretionary
- CNTB Health Care
- Exchange
- ANGH Nasdaq
- CNTB Nasdaq
- Market Cap
- ANGH 47.5M
- CNTB 55.2M
- IPO Year
- ANGH N/A
- CNTB 2021
- Fundamental
- Price
- ANGH $0.65
- CNTB $0.71
- Analyst Decision
- ANGH
- CNTB Strong Buy
- Analyst Count
- ANGH 0
- CNTB 1
- Target Price
- ANGH N/A
- CNTB $8.00
- AVG Volume (30 Days)
- ANGH 27.0K
- CNTB 17.3K
- Earning Date
- ANGH 04-11-2025
- CNTB 03-31-2025
- Dividend Yield
- ANGH N/A
- CNTB N/A
- EPS Growth
- ANGH N/A
- CNTB N/A
- EPS
- ANGH N/A
- CNTB N/A
- Revenue
- ANGH $52,274,011.00
- CNTB $26,033,000.00
- Revenue This Year
- ANGH N/A
- CNTB $997.61
- Revenue Next Year
- ANGH N/A
- CNTB N/A
- P/E Ratio
- ANGH N/A
- CNTB N/A
- Revenue Growth
- ANGH 13.03
- CNTB N/A
- 52 Week Low
- ANGH $0.61
- CNTB $0.55
- 52 Week High
- ANGH $2.27
- CNTB $2.66
- Technical
- Relative Strength Index (RSI)
- ANGH 50.77
- CNTB 35.88
- Support Level
- ANGH $0.65
- CNTB $0.55
- Resistance Level
- ANGH $0.76
- CNTB $0.84
- Average True Range (ATR)
- ANGH 0.05
- CNTB 0.08
- MACD
- ANGH 0.00
- CNTB -0.02
- Stochastic Oscillator
- ANGH 58.60
- CNTB 28.06
Stock Price Comparison Chart: ANGH vs CNTB
About ANGH Anghami Inc.
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with the catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner and is continuously licensing new content.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.